AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06359444 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Combined aerobic + strength training
Description: Participants will follow a combination of endurance and strength training for 14 weeks.~There will be three sessions every week: two at Ghent university department of rehabilitation and one at home. Each session will last approximately one hour.
Study NCT06359444 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Combined strength + HIIT training
Description: 6 weeks of endurance training and strength training, 8 weeks of strength training and HIIT.~Participants will follow the same combination of endurance and strength training for the first six weeks, to build up to a baseline level of physical fitness. They will then switch to eight weeks of a combination of strength training and High Intensity Interval Training (HIIT).~There will be three sessions every week: two at Ghent university department of rehabilitation and one at home. Each session will last approximately one hour.
Study NCT05877742 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AA group
Description: Participants will individually receive a 5-minute AA education delivered verbally at his/her respective clinic by a trained nursing student interventionist in addition to the usual scheduled follow-ups and activities at clinics.
Study NCT05877742 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control group
Description: To mimic the time and attention spent, the control group will individually receive a 5-minute seminar delivered by an RA.
Study NCT05165693 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental Formula
Description: Diabetes-specific study formula
Study NCT05165693 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Test Meal
Description: Instant oatmeal
Study NCT05231512 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Respiratory Music Therapy Protocol
Description: Participants will engage in eight (8) 45-minute virtual music therapy groups containing up to 6 participants over the course of 8 weeks. Within these groups, participants will be invited to use instruments provided including a Yamaha recorder and a Grover Trophy slide whistle. 45 minute virtual music therapy sessions facilitated by board-certified music therapy will consist of music-assisted relaxation through music visualization, followed by gentle pulmonary exercise via wind instrumental playing, and concluding with group singing.
Study NCT05766878 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: implants placement
Description: The intervention will consist of placement of two types of short implants (one with traditional machined collar and one with anodized collar). After their healing period, the prosthetic rehabilitation will be made.
Study NCT05766878 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: implants placement
Description: The intervention will consist of placement of two types of short implants (one with traditional machined collar and one with anodized collar). After their healing period, the prosthetic rehabilitation will be made.
Study NCT04791306 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: supervised exercise training
Description: Participates perform once a week for 4 months an in-house supervised endurance and strength training.
Study NCT04791306 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: home-based exercise training
Description: Participants are provided with an application for planning and documentation of their physical activity, together with an expert participants plan their physical activities for their home-based training to reach at least 150 min physical activity per week.
Study NCT05189353 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ghrelin
Description: Ghrelin infusion
Study NCT05189353 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Ghrelin
Description: Ghrelin infusion
Study NCT05189353 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Saline infusion
Study NCT05189353 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Saline infusion
Study NCT06357676 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT06357676 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Biopsy
Description: Undergo bone marrow biopsy
Study NCT06357676 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT scan or FDG PET/CT
Study NCT06357676 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Echocardiography
Description: Undergo echocardiography
Study NCT06357676 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: FDG-Positron Emission Tomography
Description: Undergo FDG PET/CT
Study NCT06357676 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Glofitamab
Description: Given IV
Study NCT06357676 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibrutinib
Description: Given PO
Study NCT06357676 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT06357676 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Obinutuzumab
Description: Given IV
Study NCT05664984 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 1-face-to-face
Description: The cognitive rehabilitation intervention consists of 45-minute sessions, 2 days a week for 12 weeks. The same rehabilitation intervention program was applied to both groups by face-to-face or tele-rehabilitation method. The main purpose of the study is to see the effectiveness of cognitive rehabilitation intervention in the elderly with amnestic mild cognitive impairment and to compare the two methods.
Study NCT05664984 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 2-tele rehabilitation
Description: 2-tele rehabilitation
Study NCT05522166 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Digital Stories and Face-to-face Basic Life Support Trainings
Description: In this study, digital storytelling and face-to-face applied techniques will be given to teacher candidates via social media (Whatsapp) and the impact of these trainings on the knowledge and skill levels of teacher candidates will be evaluated comparatively.
Study NCT06237894 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multisensory Stimulation
Description: Multisensory Stimulation
Study NCT04625127 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Treadmill gait training with GaitBetter
Description: Participants will receive gait training with the GaitBetter solution for a total of 15 sessions (3 days a week for 5 weeks) each lasting approximately 45 minutes.
Study NCT04625127 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Treadmill gait training with GaitBetter + Standard of care
Description: Participants will receive gait training with the GaitBetter solution for a total of 15 sessions (3 days a week for 5 weeks) each lasting approximately 45 minutes. In addition, the investigators will record the number and duration of therapy sessions followed by the participant during standard of care.
Study NCT04625127 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard of care
Description: Participants will follow their standard of care. The investigators will record the number and duration of therapy sessions followed during standard of care.
Study NCT06549959 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Telitacicept Pre-filled Injection 80mg
Description: The patient received one treatment of Telitacicept 80mg in the test group
Study NCT04880291 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: GFB-024
Description: Peripherally acting Cannabinoid-1 receptor inverse agonist monoclonal antibody
Study NCT04880291 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matched placebo
Study NCT04765267 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Zinc sulphate heptahydrate
Description: Dietary supplements
Study NCT04765267 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Zinc sulphate heptahydrate
Description: Dietary supplements
Study NCT06392399 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: cooled radiofrequency ,
Description: In Cooled RF, after placement of the introducer needle, the 18 gauge internally cooled RF electrode is used for 90 seconds at a temperature of 60°C.
Study NCT06392399 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: conventional radiofrequency
Description: In conventional RF group lesion will be performed at 80°C for 120 seconds.
Study NCT06392399 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: neurolysis of ganglion
Description: In neurolytic block, Once the position of the needle tip confirmed, 4 - 6 mL of 8% phenol in saline will be injected followed by 1 mL of saline to avoid the deposition of phenol within the intervertebral disc material.
Study NCT05202340 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT05126251 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tangningtongluo tablet
Description: Tangningtongluo Tablet is an in-hospital preparation of Guizhou bailing. It is used for diabetes caused by deficiency of Qi and Yin. The symptoms include thirst, drinking, overeating, polyuria, weight loss, shortness of breath, fatigue, hand, foot and heart heat and blurred vision; Type 2 diabetes and diabetic retinopathy see the above syndrome. The present study shows that Tangningtongluo Tablet have certain hypoglycemic effects in diabetic animal models and diabetic patients, and may improve insulin sensitivity in diabetic mice.It is speculated that the drug may be effective for prediabetes. (0.4g/tablet,Plate(12 pills/plate ×3 plates/box))
Study NCT05126251 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: lifestyle intervention
Description: Avoid overeating, avoid large intake of high-calorie, high-fat foods, live a regular life, avoid sitting for a long time, strengthen exercise and reduce weight.
Study NCT05126251 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: lifestyle intervention
Description: Avoid overeating, avoid large intake of high-calorie, high-fat foods, live a regular life, avoid sitting for a long time, strengthen exercise and reduce weight.
Study NCT06426589 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resistence training and mediterranean diet
Description: Resistance training. Subjects assigned to the experimental group participated in resistance program twice a week (on Tuesdays and Thursdays) for a period of 12 weeks, totaling 24 sessions of 60 minutes each. Each session during this time was divided into three clearly differentiated parts: i) 5-minute warm-up comprised of a series of gentle, low-intensity exercises designed to gradually prepare the muscles and joints of older adults for the main exercise.~Mediterranean Diet. In addition to the resistance intervention, the experimental group received a Mediterranean diet protocol based on the study by Ismail et al. \[34\] with the following meal plan: i) carbohydrates constituted 50% of daily intake; ii) fats repre-sented 35%; and iii) proteins accounted for 15%.
Study NCT04119830 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Given IV
Study NCT04119830 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT04119830 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rintatolimod
Description: Given IV
Study NCT05409534 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Backward Walking (Exercise group)
Description: The participant will apply a maximum of 40-50 minutes of exercise, including 10 minutes of warm-up exercise, 30 minutes of backward walking training and 10 minutes of cooling-off exercise. The maximum time to do backward walking training will be 30 minutes. In the backward walking exercise, 1 set will take 5 minutes. The maximum number of sets that can be made will be 6 sets. No more than 6 sets will be made.
Study NCT05409534 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Forward Walking (Control Group)
Description: The participant will apply a maximum of 40-50 minutes of exercise, including 10 minutes of warm-up exercise, 30 minutes of forward walking training and 10 minutes of cooling-off exercise as the home exercise programme.
Study NCT05646017 — intervention group
Intervention type: DEVICE
Intervention: Intermittenly scanned continuous glucose monitoring
Description: Use of Intermittenly scanned continuous glucose monitoring (FreeStyle Libre)
Study NCT05949502 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Beautifil II LS (Low-Shrinkage)
Description: low shrinkage bioactive material Giomer
Study NCT05949502 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 3M Filtek Z250 XT Universal
Description: Universal Nano-hybrid composite
Study NCT05254847 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine combined with lenvatinib and tislelizumab
Description: Capecitabine combined with lenvatinib and tislelizumab
Study NCT05526040 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Immunonutrient-enriched oral nutrition supplementation
Description: Individualized dietary assessment and counselling with additional high energy, high protein, immunonutrient-enriched oral nutrition supplement; taken 3 servings per day, from 1 week prior to cancer treatment and continued throughout the cancer treatment.~Oral Impact® is an oral nutrition supplement product enriched with arginine (3.3g/sachet), omega-3 fatty acids (0.8g/sachet) and nucleotides (0.3g/sachet). The immunonutrient-enriched formula is also a complete and balanced formula, and is gluten free. The osmolality of the formula is 620 mOsm/kg water.
Study NCT05526040 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Standard medical nutrition therapy
Description: Individualized dietary assessment and counselling and standard nutrition supplementation via oral nutrition supplementation or enteral nutrition as necessary.
Study NCT06549959 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Telitacicept Freeze-dried powder Injection 80mg
Description: The patient received one treatment of Telitacicept 80mg in the test group
Study NCT05657574 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D377
Description: oral, once daily, 8 weeks
Study NCT05949229 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Duloxetine 60 MG
Description: Patients will recieve 2-hour preoperative duloxetine
Study NCT05949229 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duloxetine 60 MG
Description: Patients will recieve 2-hour preoperative duloxetine
Study NCT05649995 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pain science education driven physiotherapy program
Description: Pain science training will be carried out as described by Moseley and Butler. Topics covered within the scope of pain science education are planned to include: neurophysiology of pain, synapses, peripheral sensitization, central sensitization, plasticity of the nervous system. The aim of the training will be to teach participants that pain is a multifactorial experience rather than just tissue injury. Participants in this group will be told about the importance of physical activity integrated with pain science education (i.e., explaining that physical activity is the key to bioplasticity and causing changes in our system) and why sedentary behaviors should be reduced (reducing sedentary behaviors reduces the overprotectiveness of the pain system).
Study NCT05649995 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Biomedical education driven physiotherapy program
Description: Participants in this group will be planned to increase their knowledge of knee anatomy, knowledge of knee OA and knee OA risk factors, and the importance of increasing physical activity and reducing sedentary behavior in reducing osteoarthritic pain and improving overall health. The importance of physical activity by integrating it with biomedical education (as physical activity can help strengthen muscles, protect joint function, and improve sleep and general health) and the necessity of reducing sedentary behaviors will be discussed within the framework of biomedical education.The main difference of standard education from pain science education will be that it does not contain information about pain mechanisms mentioned in pain science education.
Study NCT05657574 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: D377
Description: oral, once daily, 8 weeks
Study NCT05657574 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: CKD-331
Description: oral, once daily, 8 weeks
Study NCT05657574 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-331
Description: oral, once daily, 8 weeks
Study NCT05657574 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: D086
Description: oral, once daily, 8 weeks
Study NCT05657574 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo (for D377)
Description: oral, once daily, 8 weeks
Study NCT05657574 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo (for CKD-331)
Description: oral, once daily, 8 weeks
Study NCT05657574 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo (for D086)
Description: oral, once daily, 8 weeks
Study NCT05657574 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo (for D086)
Description: oral, once daily, 8 weeks
Study NCT05380479 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mirtazapine
Description: mirtazaine15 mg tablet daily for 8 weeks.
Study NCT05380479 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Megestrol Acetate
Description: megestrol acetate 160 mg tablet daily for 8 weeks.
Study NCT06531551 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The group to which Acupressure will be applied in each fraction
Description: Acupressure application protocol will be started after patient information. This process is planned to take 30 minutes.Before the application, approximately 20 seconds of warming and rubbing without direct pressure on the acupressure points will be performed to reduce tissue sensitivity and prepare the points for acupressure. Subsequently, the researcher will apply pressure with the thumb on the predetermined acupressure points, considering the individual's pain threshold, with 10 seconds of pressure followed by two seconds of relaxation without lifting the finger, in consecutive presses following the rhythm of breathing. A digital clock (belonging to the researcher) will be used to determine the duration of the acupressure application.
Study NCT00742833 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KUC-7483
Study NCT00742833 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT05987995 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endometrial injury
Description: A pipelle endometrial sampler was introduced gently into the uterine cavity. The inner piston of the catheter was withdrawn to create suction, and injury (scratching) of the endometrium was done by moving the pipelle catheter up and down within the uterine cavity
Study NCT05818969 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hypnosis Therapy
Description: Pre-recorded hypnosis therapy audio recording with accompanying visual of a calming ocean scene to be played at least once daily for 7 days preoperatively.
Study NCT04201808 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tenofovir Alafenamide 25 MG
Description: All patients will receive Tenofovir Alafenamide, 25mg PO, to treat chronic hepatitis B and their previous suboptimal response over the study duration of 48 weeks. Patients will be followed every 12 weeks for medication adherence, medication refill, and follow up as per standard of care.
Study NCT06436599 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: plane block with %0.25 30 ml bupivacaine
Description: evaluation of the efficacy of two different plan blocks for postoperative anaesthesia
Study NCT06053190 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sentence stimulus
Description: The sentences are designed such that a specific target word is either (a) Plausible (normal), (b) a semantic pragmatic violation, or (c) a morpho-syntactic violation. Example: e.g., Every morning at breakfast, the boys would (A: EAT)/ (B.PLANT )/ (C. EATS ) eggs...
Study NCT06053190 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Speaking style
Description: The sentences will be presented either in A. conversational speaking style, or B. hyper-articulated clear speech style. Clear and conversational speech samples will be elicited from a single male talker. In the conversational speech condition, which will be recorded first, the talker will be instructed to read the sentences as they would in everyday conversation. In the clear speech condition, the talker will be instructed to produce the sentences as if they would if they were talking to a person with hearing loss.
Study NCT05526404 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dieta mobile application
Description: Mobile application that functions on mobile phones and allows for tracking of symptoms, dietary intake, and stool characteristics using logs and pictures. Users of the application track symptoms by completing questionnaires regarding stool frequency, consistency, and mental status changes. Users can track dietary intake and stool characteristics by taking time-stamped photos of all dietary intake and bowel movements.